Suchergebnisse - "Cascavilla, Nicola"

PubPharm (220)

1

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

2

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera : 5-year drug survival and efficacy outcomes

enthalten in: Annals of hematology | 2024

von Barbui, T. | Carobbio, A. | De Stefano, V. | +38

3

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes

enthalten in: Annals of hematology | 2023

von Barbui, T. | Carobbio, A. | De Stefano, V. | +38

4

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia : an open-label, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lübbert, M. | Wijermans, P. | Kicinski, M. | +83

CommentIn: Lancet Haematol. 2023 Nov;10(11):e866-e867. - PMID 37914474

5

Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients : subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese"

enthalten in: Leukemia & lymphoma | 2023

von Mele, G. | Di Renzo, N. | Cascavilla, N. | +21

6

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia : Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Oliva, E. | Riva, M. | Niscola, P. | +39

CommentIn: J Clin Oncol. 2023 Oct 1;41(28):4465-4468. - PMID 37428990

7

AVALON : The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

enthalten in: Cancer | 2023

von Todisco, E. | Papayannidis, C. | Fracchiolla, N. | +46

8

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM) : results from an international, double-blind, randomised, controlled, phase 3 study

enthalten in: Lancet (London, England) | 2023

von Verstovsek, S. | Gerds, A. | Vannucchi, A. | +125

CommentIn: Lancet. 2023 Jan 28;401(10373):248-249. - PMID 36709064

9

AVALON : The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

enthalten in: Cancer | 2023

von Todisco, E. | Papayannidis, C. | Fracchiolla, N. | +45

10

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera

enthalten in: NEJM evidence | 2023

von Barbui, T. | Vannucchi, A. | De Stefano, V. | +35

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]